BioCryst’s (BCRX) sole marketable drug, Orladeyo reports preliminary sales for the fourth quarter. The company also provides its revenue guidance for 2022.
Business, Services And Guides For Music Labels
Business, Services And Guides For Music Labels
BioCryst’s (BCRX) sole marketable drug, Orladeyo reports preliminary sales for the fourth quarter. The company also provides its revenue guidance for 2022.